Acciones Isodiol International Inc Canadian Securities Exchange
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 26,09 M 17,67 M | Ventas 2019 | 22,25 M 30,33 M 20,54 M | Capitalización | 49,96 M 68,11 M 46,13 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -49,08 M -33,24 M | Resultado Neto 2019 | -126 M -172 M -116 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 21,2 M 14,36 M | Deuda neta 2019 | 5,22 M 7,12 M 4,82 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+22,67 % | 5557,16 M | |
-35,41 % | 3521 M | |
-4,67 % | 3012,86 M | |
-25,68 % | 2651,14 M | |
-11,58 % | 2304,23 M | |
+41,79 % | 1906,85 M | |
+39,77 % | 1503,26 M | |
-15,65 % | 1411,99 M | |
+44,76 % | 1372,93 M |